Lysophosphatidylcholine is the major lysophospholipid in mammalian tissues and has been shown to be cytolytic at high concentrations. In the present study we demonstrated that the level of lysophosphatidylcholine was significantly increased in the heart of rats fed with a vitamin E-deficient diet. Moreover, the cardiac lysophosphatidylcholine level was decreased in rats fed with a high vitamin E diet. The alterations in cardiac lysophosphatidylcholine level by dietary vitamin E were attributed to the changes in the activity of cardiac phospholipase A. Dietary vitamin E affected both phospholipase A1 and A2 in the same manner, but had no effect on the other major enzymes which are responsible for the metabolism of lysophosphatidylcholine. Kinetic studies revealed that the inhibition of enzyme activity by vitamin E was essentially non-competitive. The accumulation of lysophosphatidylcholine in the rat heart may be one of the underlying biochemical causes of the observed cardiac dysfunctions produced during vitamin E deficiency.
INTRODUCTION
The principal catabolic pathway for phosphatidylcholine, the major phospholipid in mammalian tissues [1] , is through the hydrolytic action of phospholipase A1 or A2, which releases an acyl group and results in the formation of lysophosphatidylcholine [2] . Lysophosphatidylcholine can be further deacylated by lysophospholipase or, alternatively, it can be reacylated to the parent phospholipid through the reacylation reaction. The deacylation-reacylation process is not only an important mechanism for the-remodelling of the acyl groups in phospholipids [3] , but also serves as the principal pathway by which lysophospholipids are removed from the cell. Since all lysosphospholipids are cytolytic at high concentrations, the maintenance of normal cellular function necessitates a rigid control of its transient presence [4] . This is achieved by the combined action of phospholipase A, lysophospholipase and acylCoA acyltransferase.
A significant increase in lysophosphatidylcholine was observed in the liver of vitamin E-deficient rats [5] . Such an increase was attributed to an increase in mitochondrial phospholipase A2 activity [5] . More recently, we demonstrated a direct inhibitory effect of vitamin E on platelet phospholipase A2 [6] . These studies clearly show that vitamin E may act as a modulator of phospholipid metabolism in mammalian tissues. Although the effect of vitamin E on cardiac phospholipid metabolism had not been studied, electrocardiac abnormalities and cardiac necrosis as a direct result of vitamin E deficiency in the rabbit heart have been well documented [7] . Abnormalities in membrane conductivity and subsequent necrosis appeared to originate from the membrane defects that might result from altered phospholipid metabolism. In the present study we provide evidence that cardiac phospholipase A activity and, consequently, the level of lysophosphatidylcholine in the heart, can be regulated by dietary vitamin E levels. [8, 9] . The animal was put under light diethyl ether anaesthesia and a sample of blood was obtained by aortic puncture [6] . The heart was rapidly removed and stored at -70°C until used. Preparation of subcellular fractions from rat heart Each rat heart was cut into small pieces and homogenized in 10 ml of 20 mM-Tris/HCl buffer, pH 7.5, containing 0.25 M-sucrose and 1 mM-EDTA at 4 'C. The subcellular fractions were prepared by differential centrifugation and the cross-contaminations between fractions were determined as described previously [10] .
MATERIALS AND METHODS

Preparation of labelled phosphatidylcholine
Labelled phosphatidyl[Me-3H]choline was prepared by perfusion of [Me-3H]choline into the isolated rat heart as described previously [11] . Before perfusion, the lipids were extracted from the heart and the labelled phosphatidylcholine was separated by t. [11] . The conditions of the assay were identical with those described in the preceding sub-section. After the reaction, radioactivities in the fatty acid and lysophosphatidylcholine fractions were determined. Phospholipase A, activity was calculated from the amount of radioactivity in the lysophosphatidylcholine fraction, whereas phospholipase A2 activity was estimated in the same manner from the fatty acid fraction. Lysophospholipase assay Lysophospholipase activities in microsomal and cytosol fractions of rat hearts were assayed with 1-[1-14C]-palmitoyl-sn-glycero-3-phosphocholine [12] . The reaction mixture (0.5 ml) contained 20 mM-Tris/HCl (pH 7.0), 0.2 mm labelled lysosphosphatidylcholine (1200 d.p.m./nmol) and 0.3-0.5 mg of enzyme protein.
The reaction was initiated by the addition of microsomal or cytosol preparation. After incubation at 37°C for 30 min, the reaction was terminated by the addition of chloroform/methanol (2: 1, v/v). The lipids were separated by t.l.c. with, as solvent system, chloroform/ methanol/water/acetic acid (70:30:4:2, by vol.). Enzyme activity was calculated from the radioactivity associated with the fatty acid fraction. PartiWl purification of phospholipase A from rat cytosol Rat heart cytosol (20 ml) was applied to a column (1 cm x 21 cm) of CM-cellulose equilibrated with 50 mmHepes buffer/S mm-EDTA, pH 7.4. The column was washed with 120 ml of the same buffer, followed by the application of a linear gradient of 0-0.5 M-NaCl in 200 ml of the same buffer. Each fraction was assayed for phospholipase A activity. Most phospholipase A (containing both phospholipase A, and A2 activities) was eluted from the column at 0.1 M-NaCl. The fractions containing high enzyme activity were pooled and used for kinetics studies.
Other determinations
Plasma pyruvate kinase activity [9] and lysophosphatidylcholine: acyl-CoA acyltransferase activities from the subcellular fractions of the rat heart were determined by procedures described in earlier studies [13] . Serum tocopherol was determined by h.p.l.c. [14] . The lipid phosphorus of the phospholipid fractions isolated by t.l.c. was determined by the procedure of Bartlett [15] . Protein was determined by the method of Lowry et al. [16] , with bovine serum albumin as standard. Analysis of data Radioactivity was determined with an LKB liquidscintillation counter. Counting efficiency was calculated by the channel-ratios calibration method. Student's t test was used for statistical analysis. The level of significance was set at P < 0.05.
RESULTS
Vitamin E status of animals
The plasma pyruvate kinase activity, an indicator of myopathy, and plasma tocopherol levels were used to verify the vitamin E status of the rats. Pyruvate kinase activities in the vitamin E-deficient rats were markedly elevated in comparison with rats fed with 50 or 5000 p.p.m. dietary vitamin E. Plasma tocopherol levels, quantified by h.p.l.c., were found to be significantly different in all three groups of rats. The differences are in accordance with the level of vitamin E present in the diets (Table 1) [6] . There were no significant differences in body weight or heart weight among these three groups of rats. Rat hearts were homogenized in 20 mM-Tris/HCl/ 0.25 M-sucrose, pH 7.5, and lipids were extracted from a portion of the homogenate by the procedure described by Folch [17] . The phospholipid classes were separated by t.l.c., and the amount of lipid phosphorus in each fraction was determined. As depicted in Table 2 , no significant difference in major cardiac phospholipids was detected between the animal groups. However, levels of lysophosphatidylcholine were significantly elevated in the heart of the rats fed the vitamin E-deficient diet.
Effect of vitamin E on rat heart phospholipase A Since phospholipase A (both phospholipase A1 and A2) is the major enzyme responsible for the generation of lysophosphatidylcholine, its activity in the subcellular fractions of the rat heart among the three animal groups was measured. Phospholipase A activity was determined with phosphatidyl[Me-3Hlcholine as substrate, enzyme activity being estimated by the amount of radioactivity from the lysophosphatidylcholine fraction after the reaction (Table 3) . Enzyme activities were significantly elevated (P < 0.05) in all subcellular fractions of vitamin E-deficient-rat hearts when compared with those of Vol. 247 Effect of exogenous vitamin E on the activty of phospholipase A The direct effect of vitamin E on phospholipase A activity in the rat heart was investigated. Different amounts of a-DL-tocopherol were added to the subcellular fractions before enzyme assays. Addition of vitamin E markedly lowered phospholipase A activity in all rat heart subcellular fractions (Fig. 2) . Over the range of vitamin E tested (0.025-1.0 mM), the magnitude of inhibition was similar among various cardiac subcellular fractions.
In order to understand better the mechanism of inhibition by vitamin E, rat heart cytosolic phospholipase A was partially purified by column chromatography, and the fractions that contained high phospholipase A activities devoid of lysophospholipase activity were pooled and used for kinetic studies. Fig. 3 shows that partially purified phospholipase A activities were also inhibited by added tocopherol in a dose-dependent manner. The double-reciprocal plot clearly indicates that the nature of inhibition was essentially non-competitive. Effect of vitamin E on lysophospholipase and lysophosphatidycholine:acyl-CoA acyltransferase activities
The significant increase in lysophospholipid from the vitamin E-deficient rat hearts depicted in Table 2 could be due to an increase in endogenous phospholipase A activities, or, conversely, decreases in lysophospholipase or lysophosphatidylcholine: acyl-CoA acyltransferase activity. Hence the activities of these two major enzymes responsible for the metabolism of lysophosphatidylcholine in the heart subcellular fractions of the three vitamin E-supplemented (50 or 5000 p.p.m.)-rat hearts. In addition, enzyme activities in the hearts of the 5000 p.p.m.-vitamin E-supplemented groups appeared to be generally lower than those supplemented with 50 p.p.m. of vitamin E. Statistical analysis revealed that differences between the phospholipase A activities in the 50 p.p.m.-and the 5000 p.p.m.-vitamin E-supplemented groups were significant (P < 0.05) only in the mitochondrial and microsomal fractions.
From the above-mentioned study it appears that the hydrolysis of acyl groups of phosphatidylcholine in the rat heart was inhibited by increasing dietary vitamin E. Whether such inhibition affects both phospholipase A1 and A2 in the same manner was not known. In order to assess each phospholipase A activity independently in the same assay, we used 1-stearoyl-2-[14C]-arachidonylglycerophosphocholine as substrate. Phospholipase A1 activity was estimated from the radioactivity present in the lysophosphatidylcholine fraction, whereas phospholipase A2 activity was determined from the radioactivity associated with the released free arachidonate. As shown in Fig. 1 , both phospholipase A1 and A2 activities in the microsomal fractions were found to be higher in the vitamin E-deficient group than those in the vitamin-fed groups. The magnitude of inhibition by dietary vitamin E was similar for both phospholipases. Enzyme activities were inversely related to the amount of vitamin E present in the diets. The subcellular fractions from normal rat hearts were preincubated with a-DL-tocopherol for 10 min at 37°C before assay. phospholipase A in the presence or absence of a-DL-tocopherol Partially purified rat heart cytosolic phospholipase A (40 ,ug) was incubated in the absence (0) or in the presence of 50 sM-(A) or 500 #M-(-) a-DL-tocopherol for 10 min at 37 'C. The reaction was initiated by the addition of phosphatidyl[Me-3H]choline as substrate. Enzyme activity was calculated from the amount of radioactivity associated with the lysophosphatidylcholine fraction after the reaction. Each point represents the mean for three separate determinations. animal groups were determined. As depicted in Table 4 , there is no significant difference in the activities of cardiac lysophospholipase or acyltransferase in the subcellular fractions among the three animal groups. Our results thus indicate that dietary vitamin E has no effect on the enzymes of lysophospholipid metabolism.
DISCUSSION
Although the inhibition of phospholipase A activity by vitamin E has been reported in the liver and platelets [5, 6] , this is the first study to show that this key enzyme of phosphatidylcholine catabolism in the rat heart is also inhibited by vitamin E. It is clear from the present study that the vitamin E status in the animal is an important biochemical factor for the maintenance of lysophosphatidylcholine levels in the heart. Since the vitamin E content in the cardiac tissue has recently been shown to be directly proportional to dietary vitamin E intake [18] , our results indicate that there is a reverse relationship between phospholipase A activity in the rat heart and the tocopherol content of the tissue. The other lysophosphatidylcholine metabolic enzymes in the heart are not affected by the vitamin E status of the animal.
It is noteworthy that phosphatidylcholine isolated from the heart was used as substrate for the assay of phospholipase A activity. Cardiac phospholipase A was found to display acyl-group-specificity towards certain phosphatidylcholine species [11] . The problems and limitations of using synthetic substrates (with defined acyl groups) for the studies of phospholipase A in mammalian tissues have been well-documented [11, 19] . We consider that the use of a natural substrate (with mixed acyl groups) would provide us with a better assessment of enzyme activity. Owing to the difficulties in obtaining uniform labelling of the different acyl groups in the natural substrate, the radioactive label was placed at the base group. The use of phosphatidyl[Me-3H]-choline as substrate allowed us to assay for the sum of phospholipase A1 and A2 activities simultaneously [11] by monitoring the formation of lysophosphatidyl[Me-3H]choline. In order to discriminate the effect of vitamin E between phospholipase A1 and phospholipase A2, it was necessary to use a phospholipid substrate containing a labelled acyl group [11, 19] Table 3 ). Such a discrepancy was observed in our previous studies [11] and probably resulted from the specificity of the enzyme towards phosphatidylcholine with an arachidonyl group [11] as well as the difference in the dispersion of substrates. Since lysophospholipase activity is present in the cytosolic and microsomal fractions [11, 20] , the addition of unlabelled lysophosphatidylcholine in the assay mixture was shown to be effective in the inhibition of the hydrolysis of the labelled lysosphosphatidylcholine formed in the reaction under normal assay conditions [11] . However, the presence of high concentrations of lysophosphatidylcholine was The mechanism of inhibition of phospholipase A activity by vitamin E was examined. Although the inhibition might occur at the substrate level, kinetic studies revealed that vitamin E is a non--competitive inhibitor of phospholipase A activity. Vitamin E inhibits both phospholipase A, and A2 to similar extents, and the inhibition appears to be dose-dependent. The inhibition of the cardiac enzyme by vitamin E is similar to the previous finding that vitamin E inhibits platelet phospholipase A2 activity [6] . Apart from the release of lysophospholipids, phospholipase A2 is the principal enzyme responsible for the liberation of arachidonic acid, a rate-limiting step in eicosanoid biosynthesis.
Evidence presented in the present and in previous [5, 6] studies clearly demonstrated that vitamin E inhibits phospholipase A2 in various mammalian tissues and, thus, may contribute to the regulation of eicosanoid biosynthesis at the level of substrate release. Indeed, endogenous thromboxane synthesis in platelets was demonstrated to be inversely related to the amount of vitamin E received by normal and diabetic rats [8, 21] . The potential role of vitamin E as a nutrient regulator in decreased eicosanoid production merits further exploration.
From the results obtained in these studies we postulate that, under normal physiological conditions, phospholipase A activity in the heart is partially inhibited by vitamin E. The degree of inhibition is dependent on the vitamin E status of the animal. Cardiac phospholipase A is responsible for the production of lysophosphatidylcholine, which is further metabolized by lysophospholipase or reacylated back to the parent phospholipid by lysophosphatidylcholine: acyl-CoA acyltransferase. Since the activities of lysophospholipase and acyltransferase in the rat heart were not changed, the elevated lysophosphatidylcholine level during vitamin E deficiency may result from the increase in phospholipase A activity. If this were the case, then the regulation of phospholipase A activity in this manner could constitute an important control mechanism for the maintenance of the levels of lysophosphatidylcholine and other lysosphospholipid in the cardiac tissue. In the heart and other mammalian tissue the levels of lysophosphatidylcholine and other lysophospholipids must be rigidly regulated because of their detergent nature. High concentrations of lysophosphatidylcholine have been shown to be cytolytic [4] . Over the last few years the accumulation of lysophosphatidylcholine in the heart during ischaemia has been suggested as a biochemical cause of the development of cardiac arrhythmias [22] [23] [24] . It is therefore plausible that the accumulation of lysophosphatidylcholine in the heart of the vitamin E-deficient animal may be one of the biochemical factors preceding the cardiac dysfunctions observed in previous studies [7] .
